Department of Imaging Sciences, The Rayne Institute, Kings College London, London, United Kingdom.
J Am Coll Cardiol. 2011 Sep 6;58(11):1128-36. doi: 10.1016/j.jacc.2011.04.042.
We evaluated the relationship between acute hemodynamic response (AHR) and reverse remodeling (RR) in cardiac resynchronization therapy (CRT).
CRT reduces mortality and morbidity in heart failure patients; however, up to 30% of patients do not derive symptomatic benefit. Higher proportions do not remodel. Multicenter trials have shown echocardiographic techniques are poor at improving response rates. We hypothesized the degree of AHR at implant can predict which patients remodel.
Thirty-three patients undergoing CRT (21 dilated and 12 ischemic cardiomyopathy) were studied. Left ventricular (LV) volumes were assessed before and after CRT. The AHR (maximum rate of left ventricular pressure [LV-dP/dt(max)]) was assessed at implant with a pressure wire in the LV cavity. Largest percentage rise in LV-dP/dt(max) from baseline (atrial antibradycardia pacing or right ventricular pacing with atrial fibrillation) to dual-chamber pacing (DDD)-LV was used to determine optimal coronary sinus LV lead position. Reverse remodeling was defined as reduction in LV end systolic volume ≥15% at 6 months.
The LV-dP/dt(max) increased significantly from baseline (801 ± 194 mm Hg/s to 924 ± 203 mm Hg/s, p < 0.001) with DDD-LV pacing for the optimal LV lead position. The LV end systolic volume decreased from 186 ± 68 ml to 157 ± 68 ml (p < 0.001). Eighteen (56%) patients exhibited RR. There was a significant relationship between percentage rise in LV-dP/dt(max) and RR for DDD-LV pacing (p < 0.001). A similar relationship for AHR and RR in dilated cardiomyopathy and ischemic cardiomyopathy (p = 0.01 and p = 0.006) was seen.
Acute hemodynamic response to LV pacing is useful for predicting which patients are likely to remodel in response to CRT both for dilated cardiomyopathy and ischemic cardiomyopathy. Using AHR has the potential to guide LV lead positioning and improve response rates.
评估心脏再同步治疗(CRT)中急性血液动力学反应(AHR)与逆重构(RR)之间的关系。
CRT 可降低心力衰竭患者的死亡率和发病率;然而,多达 30%的患者并未从中获得症状改善。更多的患者未出现重构。多中心试验表明,超声心动图技术提高反应率的效果不佳。我们假设植入时的 AHR 程度可以预测哪些患者会出现重构。
研究了 33 名接受 CRT 的患者(21 名扩张型和 12 名缺血性心肌病患者)。在 CRT 之前和之后评估左心室(LV)容积。LV 腔内压力导丝评估植入时的 AHR(左心室压力最大上升率[LV-dP/dt(max)])。使用从基线(心房抗心动过缓起搏或心房颤动时右心室起搏)到双腔起搏(DDD-LV)时 LV-dP/dt(max) 的最大百分比升高来确定最佳冠状窦 LV 导联位置。RR 定义为 6 个月时 LV 收缩末期容积减少≥15%。
当采用最佳 LV 导联位置的 DDD-LV 起搏时,LV-dP/dt(max) 从基线水平(801±194mmHg/s 至 924±203mmHg/s,p<0.001)显著升高。LV 收缩末期容积从 186±68ml 降至 157±68ml(p<0.001)。18 名(56%)患者出现 RR。LV-dP/dt(max) 对 DDD-LV 起搏的升高百分比与 RR 之间存在显著关系(p<0.001)。在扩张型和缺血型心肌病中,AHR 与 RR 之间也存在类似的关系(p=0.01 和 p=0.006)。
LV 起搏的急性血液动力学反应可用于预测哪些患者在接受 CRT 治疗时可能会出现重构,无论是扩张型心肌病还是缺血性心肌病。使用 AHR 有可能指导 LV 导联定位并提高反应率。